Sarepta Therapeutics Q3 Adj. EPS $0.13 Beats $0.06 Estimate, Sales $381.400M Beat $352.961M Estimate
Benzinga Newsdesk 23 hours ago
NewsEarningsEarnings Beats
Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.06 by 116.67 percent. This is a 200 percent increase over losses of $(0.13) per share
Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.06 by 116.67 percent. This is a 200 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $381.400 million which beat the analyst consensus estimate of $352.961 million by 8.06 percent. This is a 4.50 percent decrease over sales of $399.356 million the same period last year.